Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1303 participants
OBSERVATIONAL
2022-11-14
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Machine Learning Model to Predict Outcome in Acute Hypoxemic Respiratory Failure
NCT06333002
Severe Hypoxemia : Prevalence, Treatment and Outcome
NCT02722031
Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE
NCT02010073
Predictive Model for Mortality in Older People With Critical Illness
NCT06727903
One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
NCT04457505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For model description, the investigators will extract data from the first two ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,303 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning tecniques will be implemented (Random Forest, XGBoost, Logistic regression analysis, and/or neural networks) for development of the prediction model, and the accuracy will be compared to those of existing scoring systems for assessing ICU severity (APACHE II, SOFA) and the PaO2/FiO2 ratio. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculating the respective confusion matrices and several statistics such as sensitivity, specificity, positive predictive value, and negative predictive value for mortality and duration of MV. Investigators will select the best probabilistic model with a minimum number of clinical variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Derivation cohort
It will contain 700 patients (70% of 1000 ARDS patients)
machine learning analysis
We will use robust machine learning approaches, such as Random Forest, XGBoost or Neural Networks.
Validation cohort
It will contain 300 patients (30% of 1000 ARDS patients)
machine learning analysis
We will use robust machine learning approaches, such as Random Forest, XGBoost or Neural Networks.
Confirmatory cohort
It will contain 303 patients (for external validation)
machine learning analysis
We will use robust machine learning approaches, such as Random Forest, XGBoost or Neural Networks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
machine learning analysis
We will use robust machine learning approaches, such as Random Forest, XGBoost or Neural Networks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Dr. Negrin University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesus Villar
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesús Villar, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario D. Negrin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Dr. Negrin
Las Palmas de Gran Canaria, Las Palmas, Spain
Department of Anesthesia, Hospital Clinic
Barcelona, , Spain
Hospital Universitario La Paz (ICU)
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Villar J, Ambros A, Mosteiro F, Martinez D, Fernandez L, Ferrando C, Carriedo D, Soler JA, Parrilla D, Hernandez M, Andaluz-Ojeda D, Anon JM, Vidal A, Gonzalez-Higueras E, Martin-Rodriguez C, Diaz-Lamas AM, Blanco J, Belda J, Diaz-Dominguez FJ, Rico-Feijoo J, Martin-Delgado C, Romera MA, Gonzalez-Martin JM, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. A Prognostic Enrichment Strategy for Selection of Patients With Acute Respiratory Distress Syndrome in Clinical Trials. Crit Care Med. 2019 Mar;47(3):377-385. doi: 10.1097/CCM.0000000000003624.
Huang B, Liang D, Zou R, Yu X, Dan G, Huang H, Liu H, Liu Y. Mortality prediction for patients with acute respiratory distress syndrome based on machine learning: a population-based study. Ann Transl Med. 2021 May;9(9):794. doi: 10.21037/atm-20-6624.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.